>>>>>
Pharming lodged its Biologics License Application (BLA) for Rhucin to the FDA in late December and the FDA has 60 days to accept the application, triggering the start of the regulatory approval process -- a process which is likely extend into 2012.
Keegan said he expects the FDA to accept the BLA application by the end of the month, triggering a new $5 million milestone payment from Santarus.
>>>>>
Relative Article...
http://www.reuters.com/article/2011/02/22/pharming-idUSLDE71L05F20110222?feedType=RSS&feedName=companyNews&rpc=43
STNS, Yahoo.
http://finance.yahoo.com/q?s=SNTS
There's quite a bit of stuff out on stns now, but they are still struggling financially.
http://seekingalpha.com/symbol/snts
FEATURED Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • Jun 14, 2024 2:07 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM